Roswell Park Cancer Institute

TMA 1

TMA has been designed to facilitate identification of markers differentially expressed in primary mesothelioma lesions as well as metastatic lesions. Samples from 56 patients have been incorporated: 51 patients have tissue cores from the primary lesion only, 2 patients have tissue cores from a metastatic lesion only, 1 patient has tissue cores from both the primary and recurrent lesions, and 2 patients have cores from a recurrent lesion.